Caution: For private circulation only.Please note that Money Times is for circulation among paid subscribers only. Any attempt to share your access to our website or forwarding your copy to a non-subscriber will disqualify your membership and we will be compelled to stop your supply and forfeit your subscription thereafter without any refund to you.
Although Money Times recommendation have outperformed other media, stock brokers and research houses, the brief recommendations under Money Times Talk (MTT) cannot display ‘BUY’, ‘SELL’ or ‘HOLD’ recommendations. Readers should, therefore, exercise their own judgement and evaluate the future prospects of the stock given its past performance, industry prospects in the backdrop of a growing economy and in consultation with their investment adviser.
- Coal India and BHEL may benefit as the government is likely to announce a new incentive scheme for coal gasification in the upcoming Union Budget, targeting 100 MT capacity by 2030.
- Ashok Leyland said its Lucknow manufacturing facility is a key milestone in scaling electric commercial vehicle production and strengthening its EV strategy.
- Aurobindo Pharma CuraTeQ received Health Canada approval for the biosimilar Dyrupeg, following earlier approvals in the EU and UK.
- Bank of Baroda received RBI’s in-principle approval to spin off its primary dealer business into a wholly owned subsidiary.
- Crompton launched new 70W and 80W Dynary LED lamps in the retail segment, strengthening its premium high-watt LED portfolio.
